{"id":"NCT01006291","sponsor":"Novo Nordisk A/S","briefTitle":"Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes","officialTitle":"A 26 Week Randomised, Controlled, Open Label, Multicentre, Multinational, Three-arm, Treat to Target Trial Comparing Efficacy and Safety of Three Different Dosing Regimens of Either Soluble Insulin Basal Analogue (SIBA) or Insulin Glargine With or Without Combination With OAD Treatment, in Subjects With Type 2 Diabetes Mellitus (BEGINâ„¢ : FLEX)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-11","primaryCompletion":"2010-09","completion":"2010-09","firstPosted":"2009-11-02","resultsPosted":"2015-11-13","lastUpdate":"2017-02-09"},"enrollment":687,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"insulin degludec","otherNames":[]},{"type":"DRUG","name":"insulin degludec","otherNames":[]},{"type":"DRUG","name":"insulin glargine","otherNames":[]}],"arms":[{"label":"IDeg OD FF","type":"EXPERIMENTAL"},{"label":"IDeg OD","type":"EXPERIMENTAL"},{"label":"IGlar OD","type":"EXPERIMENTAL"}],"summary":"This trial is conducted in Africa, Asia, Europe and South America. The aim of this clinical trial is to compare NN1250 (insulin degludec (IDeg) with insulin glargine (IGlar) in patients with type 2 diabetes. Subjects treated with oral antidiabetic drug(s) (OAD(s)) should continue their current OAD treatment at the stable, prerandomisation dose level and dosing frequency.","primaryOutcome":{"measure":"Change in Glycosylated Haemoglobin (HbA1c)","timeFrame":"Week 0, Week 26","effectByArm":[{"arm":"IDeg OD FF","deltaMin":-1.28,"sd":1},{"arm":"IDeg OD","deltaMin":-1.07,"sd":0.99},{"arm":"IGlar OD","deltaMin":-1.26,"sd":1.07}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":72,"countries":["Argentina","Finland","Hungary","India","Israel","Malaysia","Mexico","North Macedonia","Norway","Russia","Serbia","South Africa","Taiwan","United Kingdom"]},"refs":{"pmids":["23130654","24170235","26121451","26232910","26663320","23340894"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":230},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Headache","Diarrhoea","Back pain"]}}